Table 2.
Prenatal and postnatal comorbidities.
| HIGH (n = 28) | LOW (n = 28) | p value | |
|---|---|---|---|
| Prenatal | |||
| Multiple gestation | 5 (18) | 2 (7) | 0.42 |
| FGR/IUGR | 5 (18) | 2 (7) | 0.42 |
| Pre-eclampsia | 5 (18) | 8 (29) | 0.53 |
| Pregnancy-induced HTN | 2 (7) | 0 (0.0) | 0.75 |
| Steroids | 17 (61) | 25 (89) | 0.03 |
| Postnatal | |||
| Length of stay | 70.5 (56.0–90.0) | 74.6 (42.0–106.6) | 0.56 |
| Neuro | 7 (25) | 2 (7) | 0.14 |
| NEC | 2 (7) | 1 (4) | 1.0 |
| ROP stage ≥1 | 9 (32) | 7 (25) | 0.77 |
| BPD/CLD | 14 (50) | 13 (46) | 1.0 |
| PDA | 11 (39) | 1 (7) | 0.002 |
| ID | 6 (21) | 0 (0.0) | 0.053 |
| <7 days of life | 1 (17) | 0 (0.0) | — |
| ≥7 days of life | 5 (83) | 0 (0.0) | 0.43 |
| Mechanical ventilation | 23 (82) | 11 (39) | 0.002 |
| Average no. of comorbidities | 2.6 ± 1.8 | 1.3 ± 1.4 | 0.003 |
Categorical data represented as N (%) and continuous data are reported as median (Q1–Q3) or as mean (SD); p values are calculated by Fisher’s Exact Test.
Bold values indicate statistical significance p < 0.05.